lung cancer

News

First Patient Enrolled in the Phase 3 ELUCIDATE Trial of Pafolacianine Sodium (formerly OTL38) in the Intraoperative Identification of Lung Cancer Lesions

08/06/2020

On Target Laboratories, Inc.

WEST LAFAYETTE, Ind., July 8, 2020 /PRNewswire/ -- On Target Laboratories, Inc., a privately-held biotechnology company developing fluorescent markers to target and illuminate cancer during surgery, has announced that it has...

WEST LAFAYETTE, Ind., July 8,...

08/06/2020

IO Learning

News

Do Facility Demographics Impact Outcomes in NSCLC Patients Treated With Radiofrequency Ablation?

10/21/2018

A new study sought to determine if patient and facility demographics impacted overall survival in patients with early-stage non-small cell lung cancer (NSCLC) treated with radiofrequency (RF) ablation. Results published in the Journal of...

A new study sought to determine...

10/21/2018

IO Learning

News

Radiofrequency Ablation vs Stereotactic Body Radiotherapy in NSCLC

08/19/2018

A new study found no significant difference in overall survival (OS) for patients with early-stage non–small cell lung cancer (NSCLC) treated with either radiofrequency (RF) ablation or stereotactic body radiotherapy (SBRT). The study was...

A new study found no significant...

08/19/2018

IO Learning

The Case for Lung Ablation

07/19/2018

Interventional oncologists often report that they have difficulty making the case for continuing to perform lung ablation, but many clinicians are convinced that lung ablation should remain within the scope of practice. Alice Gillams, MB,...

Interventional oncologists often...

07/19/2018

IO Learning

News

Lung Cancer: Do High-Volume Centers Lead to Better Overall Survival?

03/20/2018

LOS ANGELES—Treating lung cancer with radiofrequency ablation (RFA) at high-volume centers is linked with improved overall survival, researchers reported in a study presented at the annual meeting of the Society of Interventional Radiology....

LOS ANGELES—Treating lung cancer...

03/20/2018

IO Learning

CIO and Lung Ablation: A Collective Exhale of Information

02/04/2018

Morning sessions review lung ablation therapies and potential for emerging technologies. By Brenda Silva As CIO 2018 continues, early sessions on day two looked to report on existing and emerging technologies for ablation with focused...

Morning sessions review lung...

02/04/2018

IO Learning

Lung Ablation Year in Review

01/25/2018

Lung ablation is an active area of research in interventional oncology, and recently published studies have given clinicians more factors to consider when determining which patients are good candidates for the procedure. In this Q&A, Stephen...

Lung ablation is an active area...

01/25/2018

IO Learning

News

Radiofrequency or microwave ablation for treatment of the lung tumors?

05/02/2017

In a prospective multi-centre randomized trial by Machi et al published in the Journal Medical Oncology (2017 May 10.1007/s12032-017-0946-x), radiofrequency ablation (RFA) and microwave ablation (MWA) are both found to be excellent in...

In a prospective multi-centre...

05/02/2017

IO Learning

News

SBRT Improves Survival for Elderly Early-Stage Lung Cancer Patients

09/28/2016

Newswise — BOSTON, September 26, 2016 -- Survival rates for elderly patients who received stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) rose from roughly 40% to 60% over the past decade,...

Newswise — BOSTON, September 26,...

09/28/2016

IO Learning

News

Advances in Radiation Therapy Have Improved Survival Rates for Early Stage Lung Cancer Patients

09/27/2016

Newswise — BOSTON, September 25, 2016 -- A new analysis of records in the Veteran’s Affairs Central Cancer Registry demonstrates a clear positive impact of the increased use of stereotactic body radiation therapy (SBRT) to treat patients with...

Newswise — BOSTON, September 25,...

09/27/2016

IO Learning